TVTX ▼ -0.3% - Travere Therapeutics, Inc.
$TVTX Travere to Present New Data Supporting FILSPARI® (sparsentan) as Foundational Treatment in IgA Nephropathy and FSGS at ASN Kidney Week 2026
02-OCT-2026 10:00 AM ET
Share this post
More filings for $TVTX
TVTX ▼ -0.0% - Travere Therapeutics, Inc.Sep 23, 2026TVTX - Travere Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026TVTX - Travere Therapeutics, Inc. - SEC Filing Update (12-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 12, 2026TVTX - Travere Therapeutics, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 7, 2026TVTX - Travere Therapeutics, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 6, 2026
View full $TVTX filing history →💬 Comments
Loading comments…
Leave a comment